Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Tuberculosis (Edinb) ; 91(5): 390-9, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21835698

RESUMO

Host responses following exposure to Mycobacterium tuberculosis (TB) are complex and can significantly affect clinical outcome. These responses, which are largely mediated by complex immune mechanisms involving peripheral blood cells (PBCs) such as T-lymphocytes, NK cells and monocyte-derived macrophages, have not been fully characterized. We hypothesize that different clinical outcome following TB exposure will be uniquely reflected in host gene expression profiles, and expression profiling of PBCs can be used to discriminate between different TB infectious outcomes. In this study, microarray analysis was performed on PBCs from three TB groups (BCG-vaccinated, latent TB infection, and active TB infection) and a control healthy group. Supervised learning algorithms were used to identify signature genomic responses that differentiate among group samples. Gene Set Enrichment Analysis was used to determine sets of genes that were co-regulated. Multivariate permutation analysis (p < 0.01) gave 645 genes differentially expressed among the four groups, with both distinct and common patterns of gene expression observed for each group. A 127-probeset, representing 77 known genes, capable of accurately classifying samples into their respective groups was identified. In addition, 13 insulin-sensitive genes were found to be differentially regulated in all three TB infected groups, underscoring the functional association between insulin signaling pathway and TB infection.


Assuntos
Antígenos de Bactérias/imunologia , Células Matadoras Naturais/imunologia , Ativação de Macrófagos/imunologia , Macrófagos/imunologia , Mycobacterium tuberculosis/patogenicidade , Linfócitos T/imunologia , Ativação Transcricional , Tuberculose/imunologia , Idoso , Análise por Conglomerados , Feminino , Predisposição Genética para Doença , Humanos , Tuberculose Latente/imunologia , Ativação de Macrófagos/genética , Masculino , Análise em Microsséries , Pessoa de Meia-Idade , Análise Multivariada , Mycobacterium tuberculosis/genética , Polimorfismo de Nucleotídeo Único , Kit de Reagentes para Diagnóstico , Reprodutibilidade dos Testes , Transdução de Sinais , Tuberculose/genética
2.
Clin Chem Lab Med ; 43(12): 1339-45, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16309370

RESUMO

BACKGROUND: Apolipoprotein A-I gene (APOA1) polymorphisms have been associated with variations in serum low-density lipoprotein (LDL)- and high-density lipoprotein (HDL)-cholesterol. We have investigated whether APOA1 common variants are also associated with variations in basal triglyceride serum concentrations and response to atorvastatin in individuals with hypercholesterolemia. METHODS: APOA1 G-75A and C83T polymorphisms and variations in serum lipids were evaluated in 150 hypercholesterolemic (HC) and 93 normolipidemic (NL) unrelated European-derived Brazilians treated with atorvastatin (10 mg/day for 4 weeks). Genomic DNA was extracted from blood leukocytes using a salting-out method and APOA1 polymorphisms were analyzed by polymerase chain reaction and restriction fragment length polymorphism. RESULTS: G-75A polymorphism was associated with differences in serum concentrations of triglyceride and very low-density lipoprotein (VLDL)-cholesterol (p=0.026) in HC men. After atorvastatin treatment, women carrying the GG/CC haplotype had lower serum triglyceride and VLDL-cholesterol (p=0.020) than non-carriers. In men, the reduction in serum triglyceride in response to atorvastatin was found to be slightly lower in GG/CC haplotype carriers (p=0.051). CONCLUSION: Our data suggest that APOA1 polymorphisms are associated with variations of baseline serum concentrations of triglyceride and VLDL-cholesterol and in response to atorvastatin in a gender-specific manner.


Assuntos
Apolipoproteína A-I/genética , Hipercolesterolemia/genética , Polimorfismo Genético , Triglicerídeos/sangue , Atorvastatina , HDL-Colesterol/sangue , LDL-Colesterol/sangue , VLDL-Colesterol/sangue , Feminino , Variação Genética , Genômica , Haplótipos , Ácidos Heptanoicos/farmacologia , Ácidos Heptanoicos/uso terapêutico , Humanos , Hipercolesterolemia/metabolismo , Masculino , Pirróis/farmacologia , Pirróis/uso terapêutico , Fatores Sexuais , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...